Stock listing
Alebund Pharmaceuticals (jiangsu) Limited Class H
Selected listing: 9637 · HKEX · HKD · HK
Alebund Pharmaceuticals (jiangsu) Limited Class H (HKEX:9637), Health Technology. Latest release Aug 7, 2026: Alebund's AP301 NDA Accepted for Review…
- Ticker
- HKEX:9637
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- HKEX
- Currency
- HKD
About Alebund Pharmaceuticals (jiangsu) Limited Class H
The company is focused on the pharmaceutical sector, contributing to advancements in healthcare. Investors can find more information about its operations and performance on its public company page.
Latest news from Alebund Pharmaceuticals (jiangsu) Limited Class H
Alebund's AP301 NDA Accepted for Review by China's NMPA
August 7, 2026
ANNOUNCEMENT OF FINAL OFFER PRICE AND ALLOTMENT RESULTS
June 26, 2026
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
June 25, 2026
Documents on Display
June 17, 2026
PHIP (1st submission)
June 14, 2026
All Alebund Pharmaceuticals (jiangsu) Limited Class H news →
Research Alebund Pharmaceuticals (jiangsu) Limited Class H
Alebund Pharmaceuticals (jiangsu) Limited Class H company profile
View the public company page for Alebund Pharmaceuticals (jiangsu) Limited Class H on 6ix.
Alebund Pharmaceuticals (jiangsu) Limited Class H news
Read company news and market updates connected to Alebund Pharmaceuticals (jiangsu) Limited Class H.
Alebund Pharmaceuticals (jiangsu) Limited Class H investor events
Find investor webinars, events, and replay context for Alebund Pharmaceuticals (jiangsu) Limited Class H.